Multiple other genes were associated with dMMR phenotypes (all associated with dMMRICA and dMMRVAE1), including the chromatin-modifying enzyme genes TRAAP in ovarian and SETD1A in breast, and the growth signaling gene MTOR in prostate cancer (and in stomach + esophagus cancer with dMMRVAE1 only at a FDR of 2%). This evidence concerns the gene SETD1A and prostate carcinoma.